|
APH1A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.338980E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.107440E-01 |
| Normal-vs-Stage2 |
3.521600E-02 |
| Normal-vs-Stage3 |
3.81680000000051E-05 |
| Normal-vs-Stage4 |
6.2779999999929E-05 |
| Stage1-vs-Stage2 |
2.222000E-01 |
| Stage1-vs-Stage3 |
5.640300E-04 |
| Stage1-vs-Stage4 |
1.276180E-03 |
| Stage2-vs-Stage3 |
2.270000E-01 |
| Stage2-vs-Stage4 |
2.989400E-01 |
| Stage3-vs-Stage4 |
8.241400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.010700E-04 |
| Normal-vs-AfricanAmerican |
1.792430E-01 |
| Normal-vs-Asian |
9.580800E-01 |
| Caucasian-vs-AfricanAmerican |
3.346200E-01 |
| Caucasian-vs-Asian |
3.275400E-01 |
| AfricanAmerican-vs-Asian |
5.925400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.849980E-04 |
| Normal-vs-Female |
1.176600E-01 |
| Male-vs-Female |
1.673940E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.154000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.676400E-03 |
| Normal-vs-Age(61-80Yrs) |
5.821700E-03 |
| Normal-vs-Age(81-100Yrs) |
3.399000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.296600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.678800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.594600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.856400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.473400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.588600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.491570E-01 |
| Normal-vs-Grade 2 |
1.859380E-01 |
| Normal-vs-Grade 3 |
2.012300E-04 |
| Normal-vs-Grade 4 |
1.59369999974679E-07 |
| Grade 1-vs-Grade 2 |
5.283700E-02 |
| Grade 1-vs-Grade 3 |
3.858300E-03 |
| Grade 1-vs-Grade 4 |
3.91290000000266E-05 |
| Grade 2-vs-Grade 3 |
2.781400E-03 |
| Grade 2-vs-Grade 4 |
3.16040000003515E-06 |
| Grade 3-vs-Grade 4 |
2.575800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.277200E-01 |
| Normal-vs-ccB subtype |
3.2489000000302E-06 |
| ccA subtype-vs-ccB subtype |
1.88209999996136E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.536200E-03 |
| Normal-vs-N1 |
7.969400E-01 |
| N0-vs-N1 |
3.299400E-01 |
|
|
